Nexalis Therapeutics Limited has released a press release.
First production completed for strong vape segment growth
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- LSH Acquires Seng Vital for Cannabis Opportunities
- Lifespot Strengthens Go-To-Market Cannabis Strategy
- Update on Unique Cannabis Vaporiser launch and Bodytel
- LSH in discussions to finance integrated cannabis producers
- B.Braun to launch Omnitest 5 BT with Body-Tel
Later from Nexalis Therapeutics
- Commercial Sales and Distribution Agreement with CBDS Health
- Amended - Appendix 4C September 2018 Quarter
- Business Development focus in rapid growth Cannabis Category
- Lifespot signs heads of agreement with ionic brands
- Production of new slim line smart vaporiser for usa
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics